While 2DG-induced glucoprivation is a useful experimental model of hypoglycemia, it does not precisely mimic the clinically relevant stimulus experienced by diabetic patients; namely insulin-induced hypoglycemia. The gene discussed is INS; the disease is Hypoglycemia.